by Dale Harrison | Oct 25, 2022 | Press Releases
Awarded patents protect novel porphyrin-conjugated compounds for selective delivery of cancer treatments SAN ANTONIO, TX – Oct. 25, 2022 – bioAffinity Technologies, Inc. (NASDAQ: BIAF; BIAFW) announced the People’s Republic of China awarded a Certificate of Patent to...
by Dale Harrison | Oct 14, 2022 | Events
October 19, 2022 bioAffinity Technologies Presents Results from Flow Cytometry Analysis of the Lung at CHEST Conference Powerful platform reveals the lung environment for diagnosing lung diseases Research Scientist Lydia Bederka, PhD, will present results of the...
by Dale Harrison | Oct 12, 2022 | Press Releases
Powerful platform reveals the lung environment for diagnosing lung diseases SAN ANTONIO, TX – Oct. 12, 2022 – bioAffinity Technologies, Inc., (NASDAQ: BIAF; BIAFW) will present results of its research into the use of flow cytometry for analyzing the lung environment...
by Dale Harrison | Sep 30, 2022 | Articles, News
Behind the Deal: Company’s decision to go public drawing capital and attention to SA SEPTEMBER 30, 2022 As published in the San Antonio Business Journal By: W. Scott Bailey – Senior Reporter, San Antonio Business Journal The move by bioAffinity Technologies Inc. to...
by Maria Zannes | Sep 28, 2022 | Press Releases
SAN ANTONIO, TX – September 28, 2022 – bioAffinity Technologies, Inc. (NASDAQ: BIAF) (NASDAQ: BIAFW) today announced the receipt of approximately $7.7 million in additional gross proceeds from the exercise of tradeable and non-tradable warrants issued in the...
